On the recordJuly 19, 2011
the medical device review process at the Food and Drug Administration in my opinion has become overly burdensome, unpredictable and inconsistent under its current leadership.
Source
congress.govEditor's note · Context
Barton criticizes the FDA's medical device review process for being inefficient.
Share & report
More from Joe Barton
Jun 21, 2018
Madam Speaker, I rise in support of the pending legislation before us. I believe it is very important that we show that we do want to address this issue, and I think the Goodlatte-McCaul bill does that in a humane way. Now, we have this…
Jul 10, 2018
I think it's good to have this and I think it's very good that we try to work to tighten up and, as the gentlelady just said, let's determine what the real intent is and then legislate accordingly.
May 10, 2018
Mr. Chairman, I can't think of a more unrewarding, difficult, fruitless issue to be asked to be the leader on than trying to find a solution to high-level nuclear waste. Can you imagine if, when you get elected to Congress, you are called…
May 22, 2018
Mr. Speaker, when I was a little boy, I used to read comic books, and one of them I read was Superman. In the Superman comic books, way back in the 1960s, Superman had an alterego that lived on Bizarro World. {time} 1615 In Bizarro World…
Other voices in this conversation
